nogutsnoglory
Moderator
- Joined
- Sep 23, 2009
- Messages
- 8,908
"RedHill is preparing to begin a potential groundbreaking Phase III study in the current quarter in North America and Israel (the MAP U.S. Study) of Crohn's disease, using a novel patent-protected formulation that combines three antibiotic ingredients in a single capsule, and is planning and preparing a parallel Phase III study in Europe (the MAP Europe Study)."
http://seekingalpha.com/article/1645962
http://seekingalpha.com/article/1645962